Browsing by Author Shi, Hongxia

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 10 of 10
Issue Date Title Author(s)
Jan-2021 Both the subtypes of KIT mutation and minimal residual disease are associated with prognosis in core binding factor acute myeloid leukemia: a retrospective clinical cohort study in single center Duan, Wenbing;Liu, Xiaohong;Zhao, Xiaosu;Jia, Jinsong;Wang, Jing;Gong, Lizhong;Jiang, Qian;Zhao, Ting;Wang, Yu;Zhang, Xiaohui;Xu, Lanping;Shi, Hongxia;Chang, Yingjun;Liu, Kaiyan;Huang, Xiaojun;Qin, Yazhen;Jiang, Hao
15-Nov-2022 Cancer-Related Gene Mutations Drive Resistance to the Third-Generation Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia Zhang, Xiaoshuai;Li, Zongru;Qin, Ya-Zhen;Gale, Robert Peter;Lai, Yueyun;Shi, Hongxia;Huang, Xiao Jun;Jiang, Qian
31-Dec-2023 Combined crystal-storing histiocytosis, light chain proximal tubulopathy, and light chain crystalline podocytopathy in a patient with multiple myeloma: a case report and literature review Zhu, Li;Wang, Lei;Shi, Hongxia;Jiang, Lei;Li, Xin;Shao, Chunying;Yan, Yu;Dong, Bao;Zou, Wanzhong;Zuo, Li
Jun-2020 Comparable Efficacy and Safety of Generic Imatinib and Branded Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia With a Consideration of Socioeconomic Characteristics: A Retrospective Study From a Single Center Dou, Xuelin;Qin, Yazhen;Lai, Yueyun;Shi, Hongxia;Huang, Xiaojun;Jiang, Qian
Jan-2021 Comparable Efficacy and Safety of Generic Imatinib and Branded Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia With a Consideration of Socioeconomic Characteristics: A Retrospective Study From a Single Center (vol 20, pg e304, 2020) Dou, Xuelin;Qin, Yazhen;Lai, Yueyun;Shi, Hongxia;Huang, Xiaojun;Jiang, Qian
Aug-2021 A Deep Learning-Based Approach for Glomeruli Instance Segmentation from Multistained Renal Biopsy Pathologic Images Jiang, Lei;Chen, Wenkai;Dong, Bao;Mei, Ke;Zhu, Chuang;Liu, Jun;Cai, Meishun;Yan, Yu;Wang, Gongwei;Zuo, Li;Shi, Hongxia
Apr-2021 Impact of socio-demographic co-variates on prognosis, tyrosine kinase-inhibitor use and outcomes in persons with newly-diagnosed chronic myeloid leukaemia Yu, Lu;Wang, Huifang;Gale, Robert Peter;Qin, Yazhen;Lai, Yueyun;Shi, Hongxia;Dou, Xuelin;Huang, Xiaojun;Jiang, Qian
Jan-2021 The loss or absence of minimal residual disease of <0 center dot 1% at any time after two cycles of consolidation chemotherapy in CBFB-MYH11-positive acute myeloid leukaemia indicates poor prognosis Duan, Wenbing;Liu, Xiaohong;Jia, Jinsong;Wang, Jing;Gong, Lizhong;Jiang, Qian;Zhao, Ting;Wang, Yu;Zhang, Xiaohui;Xu, Lanping;Zhao, Xiaosu;Qin, Yazhen;Shi, Hongxia;Chang, Yingjun;Huang, Xiaojun;Jiang, Hao
Jan-2020 Myeloid neoplasms with elevated plasmacytoid dendritic cell differentiation reflect the maturation process of dendritic cells Huang, Yumei;Wang, Yazhe;Chang, Yan;Yuan, Xiaoying;Hao, Le;Shi, Hongxia;Huang, Xiaojun;Liu, Yanrong
2009 Partially Matched Related Donor Transplantation Can Achieve Outcomes Comparable to Unrelated Donor Transplantation for Patients with Hematologic Malignancies. Huang, Xiao Jun;Xu, Lan-Ping;Liu, Kai Yan;Liu, Dai-Hong;Wang, Yu;Chen, Huan;Chen, Yu-Hong;Han, Wei;Wang, Jing-Zhi;Chen, Yao;Zhang, Xiao-Hui;Shi, Hongxia;Wang, Feng-Rong;Tang, Fei-Fei